A new trading day began on November 20, 2023, with Rallybio Corp (NASDAQ: RLYB) stock priced at $2.05, up 23.12% from the previous day of trading. During the day, the shares moved up to $2.46 and dropped to $2.00 before settling in for the closing price of $1.99. RLYB’s price has ranged from $1.96 to $9.88 over the past 52 weeks.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
Meanwhile, its annual earnings per share averaged 12.04%. With a float of $16.88 million, this company’s outstanding shares have now reached $37.84 million.
The firm has a total of 41 workers. Let’s measure their productivity.
Rallybio Corp (RLYB) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Rallybio Corp is 55.33%, while institutional ownership is 38.01%. The most recent insider transaction that took place on Mar 14, was worth 26,050. In this transaction an insider of this company bought 5,000 shares at a rate of $5.21, taking the stock ownership to the 5,000 shares. Before that another transaction happened on Mar 07, when Company’s Director sold 100,000 for $8.20, making the entire transaction worth $820,000. This insider now owns 2,378,969 shares in total.
Rallybio Corp (RLYB) Earnings and Forecasts
In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$0.45 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a return on equity of -38.65. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.04% per share during the next fiscal year.
Rallybio Corp (NASDAQ: RLYB) Trading Performance Indicators
Here are Rallybio Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 14.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -2.13 in one year’s time.
Technical Analysis of Rallybio Corp (RLYB)
Analysing the last 5-days average volume posted by the [Rallybio Corp, RLYB], we can find that recorded value of 0.25 million was better than the volume posted last year of 69873.0. As of the previous 9 days, the stock’s Stochastic %D was 12.09%. Additionally, its Average True Range was 0.39.
During the past 100 days, Rallybio Corp’s (RLYB) raw stochastic average was set at 11.09%, which indicates a significant decrease from 19.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 142.30% in the past 14 days, which was higher than the 103.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.7500, while its 200-day Moving Average is $5.4500. Now, the first resistance to watch is $2.6100. This is followed by the second major resistance level at $2.7600. The third major resistance level sits at $3.0700. If the price goes on to break the first support level at $2.1500, it is likely to go to the next support level at $1.8400. Should the price break the second support level, the third support level stands at $1.6900.
Rallybio Corp (NASDAQ: RLYB) Key Stats
With a market capitalization of 92.59 million, the company has a total of 37,794K Shares Outstanding. Currently, annual sales are 0 K while annual income is -66,650 K. The company’s previous quarter sales were 0 K while its latest quarter income was -18,370 K.